Viewing Study NCT03389659


Ignite Creation Date: 2025-12-24 @ 2:32 PM
Ignite Modification Date: 2026-02-25 @ 4:49 PM
Study NCT ID: NCT03389659
Status: UNKNOWN
Last Update Posted: 2018-01-03
First Post: 2017-12-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: XELOX/mFOLFOX Plus Vitamin D3 vs. XELOX/mFOLFOX as Firstline Chemotherapy in mCRC
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Vitamin D3 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None mCRC View
None oxaliplatin plus fluoropyrimidine View